MD Anderson Cancer Center Madrid launches a new Haematopoietic Transplant Unit Published on 27/02/2020 After more than 15 years of experience in autologous and allogeneic transplants, MD Anderson Cancer Madrid has launched a new Haematopoietic Transplant Unit with a view to enhancing and developing the transplant programme and offering CAR-T therapy.
IDH inhibitors give very positive results in relapsed acute myeloblastic leukemia patients with the mutation Published on 08/10/2019 Acting on this therapy target would give favorable results in both monotherapy and in combination with other agents, thus improving life expectancy of patients with acute myeloblastic leukemia (AML)